CX 2023: Andrew Bradbury discusses BASIL-2 trial


“I am really looking forward to seeing everyone at CX 2023 and it is going to be a great meeting. It is a pleasure and a privilege for us to be part of it and have the opportunity to present our trial data for the first time.”

Data and discussion on revascularisation treatment […]